Unknown PHASE2 INTERVENTIONAL 1-arm NCT04693000

Use of Topical Solasodine of Solanum Melongena Peel Origin in the Treatment of Palmar Arsenic Keratosis

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Interventions Arsenic Keratosis lesion or nodular size observation after 12 weeks of therapy with solasodine ointment

Updated 4 times since 2021 Last updated: Dec 31, 2020 Started: Sep 23, 2018 Primary completion: Jan 15, 2021 Completion: Jan 15, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Keratotic Nodular Size, this trial is ongoing. The trial is conducted by Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh and has accumulated 4 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2023 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Active Not Recruiting → Unknown Status
Feb 2021 — Jan 2023 [monthly]

Active Not Recruiting PHASE2

First recorded

Sep 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Data source: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Comilla, Bangladesh